Amsterdam/Oss, 20 November 2014 Sanquin Blood Supply, division Research and Okklo Life Sciences BV have entered into a research and licensing agreement for a collaborative project based on Okklo’s OCTOPlex technology. In this project, novel proprietary cyclodextrins (ring-shaped sugar molecules) will be evaluated pre-clinically for a number of (cardiovascular) indications. “We are very much …
October 2nd, 2014 Today BioAxis Research and Okklo Life Sciences have entered into an exclusive collaboration for R&D projects. Their OCTOPlex technology contributes to the rapid development of specific sugar molecules, cyclodextrins, as potential treatment for various diseases. BioAxis Research BV and Okklo Life Sciences BV have unique expertise on the design and development …
Dr Martin Feiters and Prof Dr Floris Rutjes (Institute for Molecules and Materials, Radboud University Nijmegen, the Netherlands) and Okklo Life Sciences (Oss, The Netherlands) receive a KIEM-grant for their project ‘Pervasive Cyclodextrins For Therapeutic Lipid Transfer’. In this project, a number of new cyclodextrins will be designed, synthesized and tested as potential medicines for …
Okklo Life Sciences partners with Dutch universities and SME Dr Jeroen Codee (Leiden Institute of Chemistry, Leiden), Prof Dr Hans Aerts (Medical Biochemistry, University of Amsterdam) and Dr Daniel Zollinger (Okklo Life Sciences, Oss) receive a KIEM-grant for their project ‘Designer cyclodextrins & sphingolipids involved in lysosomal storage disease’. In this project, which also involves …